Zeltiq Aesthetics Inc (ZLTQ) Files Form 4 Insider Selling : Mary Fisher Sells 1,863 Shares

Zeltiq Aesthetics Inc (ZLTQ): Mary Fisher , director of Zeltiq Aesthetics Inc sold 1,863 shares on Apr 13, 2016. The Insider selling transaction was reported by the company on Apr 14, 2016 to the Securities and Exchange Commission. The shares were sold at $30.00 per share for a total value of $55,890.00 according the SEC Form 4 Filing.

Company has been under the radar of several Street Analysts.Zeltiq Aesthetics Inc is Initiated by Brean Capital to Buy. The Rating was issued on Apr 13, 2016.Zeltiq Aesthetics Inc is Reiterated by Maxim Group to Buy while Lowering the Price Target of the company shares to $ 40 from a previous price target of $50 . The Rating was issued on Mar 1, 2016.Zeltiq Aesthetics Inc is Upgraded by Griffin Securities to Buy. Earlier the firm had a rating of Neutral on the company shares. The Rating was issued on Jan 22, 2016.

Currently the company Insiders own 21.7% of Zeltiq Aesthetics Inc shares according to the proxy statements.In the past twelve weeks, the net percent change held by company insiders has changed by -3.9%.During last six month period, the net percent change held by insiders has seen a change of -17.35%.

Shares of Zeltiq Aesthetics Inc (ZLTQ) ended Monday, Apr 11, 2016 session in red amid volatile trading. The shares closed down -0.64 points or -2.24% at $27.94 with 4,17,190 shares getting traded. Post opening the session at $28.62, the shares hit an intraday low of $27.86 and an intraday high of $29.2 and the price vacillated in this range throughout the day. The company has a market cap of $1,098 M and the number of outstanding shares has been calculated to be 3,93,10,213 shares. The 52-week high of Zeltiq Aesthetics Inc is $38.49 and the 52-week low is $18.41.

Zeltiq Aesthetics Inc Money Flow Index Chart

ZELTIQ Aesthetics Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. As of December 31 2014 it had an installed base of 3176 CoolSculpting systems installed across approximately 2688 practices across the world. As of December 31 2014 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Leave a Reply

Zeltiq Aesthetics Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zeltiq Aesthetics Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.